| Tag | Content |
|---|
EnhancerAtlas ID | HS129-06730 |
Organism | Homo sapiens |
Tissue/cell | MCF10A |
Coordinate | chr11:57192150-57193010 |
Target genes | | Number: 18 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Tcf12 | MA0521.1 | chr11:57192872-57192883 | AACAGCTGCTG | + | 6.32 | | ZNF263 | MA0528.1 | chr11:57192583-57192604 | TGAGGAGGATGAGGATGAAGC | + | 6.08 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09866 | chr11:57186394-57195934 | CD14 | | SE_40224 | chr11:57191266-57195506 | K562 | | SE_56335 | chr11:57191056-57196539 | u87 | | SE_58962 | chr11:57170849-57195646 | Ly3 | | SE_67811 | chr11:57191056-57196539 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GGGAGGTAGC AGGGAGCCAA GGACCAAGAA GGACTGAGGT ACAGTCATTC TGCATCCAAA 60
GGCTTAAATT GTAAGGGACT GGCTTTACTC TGGCTGTTTC CGGAAAGGCA GGCCCAGCCA 120
GCCCTCCCGT CTCTCTCTCT GACAGCCAAT CTCACATGTG CCTCCCTGGG AGCACCTGCT 180
CTGAGCTGTA TCAGCCCCCA GCAGGCCGCT GATTACCACT GAGCCTGGCC ACAGAGCACG 240
AGATTAGGAT GCAGCAACAC ACTGTGTGTG AGATCACGTC CCGAACCTTC TGACTCATCT 300
GCACAGGAAA CCCCCCCAGT CTCCCCTCCA GTCAGAAGGG ACCTGAAATT CCACCAGTGG 360
CAATACCAAA GAAACTTCCT ATTAGCTAAG CCCCTAGGGA GTGATTGGCT GTTGGGGCGG 420
GGAGGGGGGG CGGTGAGGAG GATGAGGATG AAGCCTGGGC AACCTGGATG TGAGGCTGTG 480
CAGGGGATGA GGACAAGGAT CCTTGGGGTG AAGGAAGAGA AGAGCAATTT TAGGTTTTGC 540
TAATTTTGTA ACCCTGGCTC CAAGCCAGCC CTTACAGGAA GTCACCCTGG CCTCCGGCTC 600
AATTCAGCAC GTGATAGGGA AGCCACATTT ATGCAGAGCA GGGAACGAGG TAAGGAAATG 660
GAAGTGGGGC TGTGGTGAAG TGGGCAAGTC TAGAGAGAGT CCCGCTGCCT GGGGCTGTTC 720
CTAACAGCTG CTGGGAGCGA GCTGCAGGTG TGGTGCCTGG CAGGGTGGCC GGGCTGTCTG 780
ACTCTGGATT TCACTCCAAG CTAGGCTGCT GCCTGAAGGA TTCCTCTTAC CCACCTTTGC 840
CTGGGCTGGC CTTTGGGACT 860
|
